Stocks On the Verge of a Comeback as Traders Eye Fresh Bounces

 bullish.beats
 
  bullish.beats
 
Follow  Message
 
 
 
Streaking.Winners tracks stocks achieving consecutive gains, focusing on consistent performers and market momentum to keep investors informed.
 

•  01 Nov 2025
 

•   BTDR  
   
  0.00%
•   EVRG  
   
  0.00%
•   GEVO  
   
  0.00%
•   GILD  
   
  0.00%
•   JNJ  
   
  0.00%

$RGEN has cooled off from recent highs but remains in a healthy technical position. Trading at $149.06, it’s hovering above key moving averages with an RSI of 52.82 right in the sweet spot for a potential bounce. With a target near $177, the risk/reward profile looks promising for a short-term upside if buyers step back in soon. Quick upside potential: moderate.

$JNJ may not move like a small cap, but it’s quietly holding its uptrend amid a wave of positive developments. Between the Nanobiotix collaboration and the expanded FDA application for Stelara, the stock’s momentum remains intact despite minor cooling. Priced at $188.87 with a target of $207, and RSI near 55, J&J’s technical setup still suggests strength in stability. Quick upside potential: steady and gradual.

$WDAY has slipped from its September peak but maintains its uptrend structure, resting just above key averages. Analysts still see it as a strong pick, supported by earnings growth and a $245 target. The RSI near 54 confirms healthy momentum without being overbought. For traders watching for a continuation bounce, Workday looks primed for a short-term recovery.

$GILD’s post-earnings pullback seems more like a breather than a breakdown. With shares at $119.79, still well above its longer-term moving averages and RSI at 56, the biotech heavyweight looks technically sound. Multiple product launches lined up for 2026 and steady earnings support the story. Quick upside potential: solid near-term rebound candidate.

$RKLB has been a quiet outperformer in the space sector. After a brief decline, it’s consolidating around $63, maintaining an upward trajectory with an RSI of 54. The growth story and analyst optimism point to continued interest. Traders could find this as an early entry spot before the next leg higher. Quick upside potential: high.

$NVTS, at $13.46, is digesting gains but holding trend support levels. Despite heavy options activity, fundamentals remain firm on AI and semiconductor tailwinds. RSI near 59 and a $17 target hint that momentum could soon resume. Quick upside potential: strong but watch volatility.

$BTDR, trading at $22.20, continues to ride the Bitcoin mining trend. Even with volume softening, the uptrend remains intact. Its 53.57 RSI and $30 target price keep the bullish case alive. The slope data suggests recent consolidation could set the stage for another climb. Quick upside potential: attractive short-term bounce.

$EVRG has been one of the more stable names in utilities, moving quietly higher over time. Now at $76.81, it’s just shy of its 52-week high, and its RSI of 50 shows room to run. The trend remains intact, with a modest but consistent upward bias. Quick upside potential: low volatility, steady gains.

$GEVO has been creeping higher at $2.34 and continues to show technical resilience. With RSI in the mid-50s and an impressive total score, it’s one of those small-cap clean energy names traders like to revisit when momentum returns. Quick upside potential: speculative but interesting.

$NBIX recently dipped but remains structurally strong. After touching $143.21, it’s consolidating with RSI near 54 and a bullish analyst outlook projecting 25% upside. Backed by institutional confidence and a clean trendline, this biotech looks ready to rebound.

View All Headlines